| 臺大學術典藏 |
2021-01-15T03:47:50Z |
Pneumatosis intestinalis and hepatic portal venous gas after CPR
|
Lai C.-F.; Chang W.-T.; Liang P.-C.; Lien W.-C.; HSIU-PO WANG; Chen W.-J. |
| 臺大學術典藏 |
2021-01-15T03:46:22Z |
Taiwanese consensus recommendations for acute pancreatitis
|
Liao W.-C.; Tu T.-C.; Lee K.-C.; Tseng J.-H.; Chen M.-J.; Sun C.-K.; Wang S.-Y.; Chang W.-K.; Chang P.-Y.; Wu M.-S.; Lin T.-J.; Lee H.-L.; Chen J.-H.; Yuan K.-C.; Liu N.-J.; Wu H.-C.; Liang P.-C.; HSIU-PO WANG; Hwang T.-L.; Lee C.-L. |
| 臺大學術典藏 |
2021 |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Tseng J.-H.; Ho M.-C.; Liao L.-Y.; Liang J.-D.; Wang C.-K.; Lee W.-C.; Shao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Lee R.-C.; Liang P.-C.; Huang K.-W.; Hu J.-T.; Kee K.-M.; Lin C.-L.; Lu S.-N.; Wang J.-H.; Chen C.-H.; Liu C.-J.; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; CHIUN HSU; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group |
| 臺大學術典藏 |
2020-12-28T08:14:10Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Chen C.-H.; Dai C.-Y.; Wang T.-E.; Su C.-W.; Wang J.-H.; Lu S.-N.; Lu S.-N.;Wang J.-H.;Su C.-W.;Wang T.-E.;Dai C.-Y.;Chen C.-H.;Chen R.-C.;Yang S.-S.;Hung C.-F.;Huang S.-F.;Liao L.-Y.;Huo T.-I.;Wu C.-C.;Lee P.-H.;Ting C.-T.;Lee W.-C.;Chau G.-Y.;Wang C.-C.;Lee K.-T.;Huang Y.-H.;Ho M.-C.;Lin S.-M.;Huang G.-T.;Chen K.-Y.;Lin X.-Z.;Hwang J.-I.;Chiou Y.-Y.;Wang C.-K.;Hu J.-T.;Chen S.-C.;Liang P.-C.;Lee R.-C.;Wu D.-K.;Lin C.-Y.;Lin C.-C.;Cheng A.-L.;Hsu C.;Chao Y.;Chen L.-T.;Wang P.-M.;Wang P.-M.;Hong J.-H.;Hsu H.-C.;Chen S.-W.;Leung S.W.;Cheng J.C.-H.;Wu J.-C.;Wu C.-Y.;Hsu Y.-C.;Hsu C.-W.;Yen-Hsuan Ni;Lin C.-L.;Local Ablation Group, Surveillance Group, Diagnosis Group, Staging Group, Surgery Group, Tace/Tare/Hai Group, Target Therapy/Systemic Therapy Group, Radiotherapy Group, Prevention Group, Drafting Group; Wang P.-M.; Chao Y.; Chen L.-T.; Hsu C.; Cheng A.-L.; Lin C.-C.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; YEN-HSUAN NI; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
| 臺大學術典藏 |
2020-12-28T06:58:50Z |
Pneumatosis intestinalis and hepatic portal venous gas after CPR
|
Chen W.-J.; Wang H.-P.; WAN-CHING LIEN; Lai C.-F.; Chang W.-T.; Liang P.-C.; Lai C.-F.;Chang W.-T.;Liang P.-C.;Wan-Ching Lien;Wang H.-P.;Chen W.-J. |
| 臺大學術典藏 |
2020-12-28T06:26:01Z |
Initial experience with the AneuRx Stent Graft for the treatment of infrarenal abdominal aortic aneurysm
|
Chen Y.-S.; HSIEN-LI KAO; Wang S.-S.; Liang P.-C.; Huang S.-C.; Ko W.-J.; Liu H.-M.; Liau C.-S.; Lin F.-Y. |
| 臺大學術典藏 |
2020-12-24T07:08:25Z |
Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient
|
Wang A.-Y.; Yuan A.; Huang C.-H.; WEI-TIEN CHANG; Liang P.-C.; Lin T.-H.; Chen S.-C. |
| 臺大學術典藏 |
2020-12-21T08:17:04Z |
Pneumatosis intestinalis and hepatic portal venous gas after CPR
|
Lai C.-F.;Chang W.-T.;Liang P.-C.;Lien W.-C.;Wang H.-P.;Wen-Jone Chen; Lai C.-F.; Chang W.-T.; Liang P.-C.; Lien W.-C.; Wang H.-P.; WEN-JONE CHEN |
| 臺大學術典藏 |
2020-12-21T01:08:30Z |
Combined Transarterial Embolization and Propranolol as Effective Treatment for Hepatic Hemangioma with Kasabach–Merritt Syndrome and Heart Failure in a Neonate
|
Hsu C.-T.; JIA-FENG WU; Liang P.-C.; Shen W.-C.; Shen W.-C.;Liang P.-C.;Jia-Feng Wu;Hsu C.-T.;Chen H.-S.;Chen H.-L.; Chen H.-S.; Chen H.-L. |
| 臺大學術典藏 |
2020-12-16T07:56:45Z |
Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient
|
Wang A.-Y.; Yuan A.; Huang C.-H.; Chang W.-T.; Liang P.-C.; Lin T.-H.; SHYR-CHYR CHEN |
| 臺大學術典藏 |
2020-12-16T07:42:34Z |
Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient
|
CHIEN-HUA HUANG; Chang W.-T.; Liang P.-C.; Lin T.-H.; Chen S.-C.; Wang A.-Y.;Yuan A.;Chien-Hua Huang;Chang W.-T.;Liang P.-C.;Lin T.-H.;Chen S.-C.; Wang A.-Y.; Yuan A. |
| 臺大學術典藏 |
2020-12-07T07:11:48Z |
Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient
|
Wang A.-Y.; Yuan A.; Huang C.-H.; Chang W.-T.; Liang P.-C.; Lin T.-H.; SHYR-CHYR CHEN |
| 臺大學術典藏 |
2020-11-19T03:20:28Z |
Alveolar hydatid disease causing total occlusion of the inferior vena cava
|
Huang J.;Wu Y.-M.;Liang P.-C.;Po-Huang Lee; Huang J.; Wu Y.-M.; Liang P.-C.; PO-HUANG LEE |
| 臺大學術典藏 |
2020-11-19T03:19:44Z |
Simulation of portal hemodynamic changes in a donor after right hepatectomy
|
Ho C.-M.;Lin R.-K.;Tsai S.-F.;Hu R.-H.;Liang P.-C.;Sheu T.W.-H.;Po-Huang Lee; Ho C.-M.; Lin R.-K.; Tsai S.-F.; Hu R.-H.; Liang P.-C.; Sheu T.W.-H.; PO-HUANG LEE |
| 臺大學術典藏 |
2020-11-19T03:19:15Z |
Diffuse cirrhosis-like recurrence of hepatocellular carcinoma after curative resection
|
Ho C.-M.; Liang P.-C.; Hu R.-H.; PO-HUANG LEE |
| 臺大學術典藏 |
2020-11-19T03:19:10Z |
Comparison of Radiofrequency Ablation and Transarterial Chemoembolization for Hepatocellular Carcinoma in the Caudate Lobe
|
Lee B.-C.;Liu K.-L.;Wu C.-H.;Huang K.-W.;Ho C.-M.;Hu R.-H.;Ho M.-C.;Wu Y.-M.;Po-Huang Lee;Liang P.-C.; Lee B.-C.; Liu K.-L.; Wu C.-H.; Huang K.-W.; Ho C.-M.; Hu R.-H.; Ho M.-C.; Wu Y.-M.; PO-HUANG LEE; Liang P.-C. |
| 臺大學術典藏 |
2020-11-03T07:37:08Z |
Taiwanese consensus recommendations for acute pancreatitis
|
Yuan K.-C.; Lee H.-L.; Chen J.-H.; Wu M.-S.; Lin T.-J.; Chang P.-Y.; Chang W.-K.; Wang S.-Y.; Sun C.-K.; Chen M.-J.; Tseng J.-H.; Lee K.-C.; Tu T.-C.; WEI-CHIH LIAO; Liu N.-J.; Wu H.-C.; Liang P.-C.; Wang H.-P.; Hwang T.-L.; Lee C.-L. |
| 臺大學術典藏 |
2020-10-14T07:24:51Z |
Association of tumour necrosis factor α promoter haplotype with chronic pancreatitis [20]
|
Chang M.-C.; Chang Y.-T.; Tien Y.-W.; Liang P.-C.; SHU-CHEN WEI; Wong J.-M. |
| 臺大學術典藏 |
2020-10-14T07:24:50Z |
Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis
|
Chang M.-C.; Chang Y.-T.; Su T.-C.; Yang W.-S.; Chen C.-L.; Tien Y.-W.; Liang P.-C.; SHU-CHEN WEI; Wong J.-M. |
| 臺大學術典藏 |
2020-10-14T07:24:50Z |
Spectrum of mutations and variants/haplotypes of CFTR and genotype-phenotype correlation in idiopathic chronic pancreatitis and controls in Chinese by complete analysis
|
Wong J.-M.; Liang P.-C.; Su Y.-N.; Jan I.-S.; Tien Y.-W.; Chang Y.-T.; SHU-CHEN WEI; Chang M.-C. |
| 臺大學術典藏 |
2020-10-14T07:24:49Z |
Association of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) mutation/variant/haplotype and Tumor Necrosis Factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis
|
Kuo C.-H.; Su Y.-N.; Su T.-C.; Liang P.-C.; Chang M.-C.; Chang Y.-T.; SHU-CHEN WEI; Wong J.-M. |
| 臺大學術典藏 |
2020-10-14T07:24:48Z |
Association of novel chymotrypsin C gene variations and haplotypes in patients with chronic pancreatitis in Chinese in Taiwan
|
Kuo C.-H.; Wong J.-M.; Su Y.-N.; Jan I.-S.; Liang P.-C.; Chang Y.-T.; SHU-CHEN WEI; Chang M.-C. |
| 臺大學術典藏 |
2020-10-14T07:24:47Z |
Lipoprotein lipase mutation S447X associated with pancreatic calcification and steatorrhea in hyperlipidemic pancreatitis
|
Chang Y.-T.; Chang M.-C.; Su T.-C.; Liang P.-C.; Su Y.-N.; Kuo C.-H.; SHU-CHEN WEI; Wong J.-M. |
| 臺大學術典藏 |
2020-10-14T07:24:43Z |
Comparison and validation of International Consensus Diagnostic Criteria for diagnosis of autoimmune pancreatitis from pancreatic cancer in a Taiwanese cohort
|
Liang P.-C.; Chang M.-C.; Jan I.-S.; Yang C.-Y.; Tien Y.-W.; SHU-CHEN WEI; Wong J.-M.; Chang Y.-T. |
| 臺大學術典藏 |
2020-10-14T07:24:42Z |
Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels
|
Wong J.-M.; Chang Y.-T.; SHU-CHEN WEI; Yang C.-Y.; Tien Y.-W.; Jan S.; Chang M.-C.; Liang P.-C. |
